G

    GRAIL, LLC (GRAL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $79.37
    -0.63 (-0.79%)

    Market Cap: $3.57B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    100%(8/8)
    Avg Surprise
    +23.34%
    Streak
    8 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-2.45
    Range$-2.98 - $-1.49
    3 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-2.21+9.6%
    60d ago$-2.37+3.1%
    30d ago$-2.37+3.1%
    7d ago$-2.38+2.9%
    Current$-2.45
    Revenue Consensus
    $44M
    Range$42M - $47M
    8 analysts
    Dec 31, 2026
    EPS Consensus$-0.84
    Range$-2.29 - $0.60
    2 analysts
    Revenue Consensus
    $55M
    Range$50M - $58M
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.84---
    Sep 26EST
    		-$-2.45---
    Jun 26
    		$-2.56$-2.91+12.03%Beat+19.5%
    Mar 26
    		$-1.37$-1.96+30.10%Beat+55.8%
    Dec 25
    		$-2.44$-2.53+3.56%Beat+15.6%
    Sep 25
    		$-2.46$-3.26+24.54%Beat+29.7%
    Jun 25
    		$-3.18$-3.56+10.67%Beat+93.8%
    Mar 25
    		$-3.10$-3.80+18.42%Beat-
    Dec 24
    		$-2.89$-4.97+41.85%Beat-
    Sep 24
    		$-3.50$-6.43+45.57%Beat-
    Jun 24
    		$-51.06N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-8.99EV/EBITDAN/A
    Price/FCF-11.55xFCF Yield-8.66%
    Profitability
    Profit Margin-236.90%Operating Margin-332.00%
    ROE-16.10%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio10.95xQuick Ratio10.74x
    Trading Statistics
    Beta3.25Avg Volume771.15K
    52-Week High$118.8452-Week Low$30.82

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$78.29
    SMA 20$74.40
    SMA 50$71.14
    SMA 200$73.24
    EMA 10$78.16
    EMA 20$75.57
    EMA 50$71.46
    EMA 200$66.71

    MACD

    Line: 3.05Signal: 2.37Hist: 0.67

    ADX

    ADX: 21.2+DI: 25.1-DI: 13.4

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down32.0
    PSAR$75.96

    Bollinger Bands

    Upper Band$85.17
    Lower Band$63.63
    %B Position2895%(Upper)
    Band Width0.73

    RSI (14-Day)

    Neutral
    57.0

    Momentum Oscillators

    Stoch %K74.6
    Stoch %D78.8
    Williams %R-32.0
    ROC (10d)13.5%
    Momentum9.42
    CCI (20d)67.9
    MFI (14d)62.5

    Volatility Measures

    ATR (14d)$5.23(6.6%)
    StdDev (20d)5.39
    Hist Vol90.5%(High)

    Volume Flow

    VWAP$78.71
    OBV-26.9M
    AD Line3.5M
    CMF (20d)0.180

    Volume Metrics

    Avg Vol (20d)791.4K
    Vol Ratio0.7x
    VWMA (20d)$73.46

    Pivot Points

    R3$86.93
    R2$84.63
    R1$82.31
    Pivot Point$80.01
    S1$77.69
    S2$75.39
    S3$73.07

    Advanced Oscillators

    TSI15.09
    Ultimate Osc52.6
    KST107.87

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$44.69M$40.78M$43.60M$36.19M$35.54M$31.84M$38.25M$28.65M$31.97M$26.72M$30.33M$20.72M
    Cost of Revenue$23.78M$21.62M$21.26M$16.45M$19.85M$18.29M$20.75M$17.41M$16.41M$15.16M$48.98M$14.32M
    Gross Profit$20.91M$19.16M$22.34M$19.74M$15.70M$13.54M$17.50M$11.24M$15.56M$11.56M$-18,650,000$6.40M
    Operating Expenses$194.69M$154.93M$146.75M$145.03M$174.55M$167.15M$154.44M$194.75M$1.66B$238.99M$175.94M$918.79M
    R&D$47.43M$48.02M$46.90M$48.65M$46.63M$53.63M$48.33M$78.23M$94.20M$101.63M$84.09M$80.08M
    SG&A$50.71M$42.77M$38.71M$37.41M$37.91M$45.07M$42.12M$47.42M$67.26M$57.07M$52.73M$50.18M
    Operating Income$-173,783,000$-135,765,000$-124,411,000$-125,291,000$-158,854,000$-153,607,000$-136,938,000$-183,507,000$-1,641,291,000$-227,422,000$-194,593,000$-912,391,000
    Interest Income$7.23M$7.99M$7.96M$6.11M$6.81M$7.78M$9.37M$11.66M$2.81M$2.90M$1.35M$2.53M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-166,708,000$-127,523,000$-116,518,000$-118,718,000$-152,856,000$-146,412,000$-126,994,000$-172,407,000$-1,638,481,000$-224,479,000$-193,029,000$-910,058,000
    Income Tax Expense$-56,461,000$-34,336,000$-17,342,000$-29,741,000$-38,871,000$-40,199,000$-29,928,000$-46,719,000$-53,144,000$-5,565,000$-187,535,000$-18,610,000
    Net Income$-110,247,000$-93,187,000$-99,176,000$-88,977,000$-113,985,000$-106,213,000$-97,066,000$-125,688,000$-1,585,337,000$-218,914,000$-5,494,000$-891,448,000
    EBITDA$-141,463,000$-103,280,000$-90,178,000$-90,638,000$-125,926,000$-121,287,000$-100,086,000$-144,838,000$-1,601,898,000$-187,383,000$-153,100,000$-872,788,000
    EBIT$-173,938,000$-135,509,000$-124,475,000$-124,825,000$-159,665,000$-154,191,000$-136,360,000$-184,068,000$-1,641,286,000$-227,380,000$-193,029,000$-912,587,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GRAL

    News

    GRAIL Inc Revenue Breakdown – LSX:A40F8M

    GRAIL Inc (LSX:A40F8M) generated 125.31 million EUR in revenue last year. The majority of this revenue, 118.01 million EUR, came from its top-performing "Screening" segment, an increase from 104.93 million EUR in the previous year. The United States was the largest geographical contributor, accounting for 116.72 million EUR in revenue.

    TradingView•8/8/26•
    Somewhat-Bullish

    CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026

    Faruqi & Faruqi, LLP is investigating potential securities claims against Grail, Inc. (NASDAQ: GRAL) and reminds investors that the deadline to seek the role of lead plaintiff in a federal securities class action lawsuit is August 4, 2026. The lawsuit alleges that Grail made false and misleading statements regarding the success likelihood of its NHS-Galleri trial, leading to a significant stock price drop after the company announced its primary endpoint was not met. Investors who purchased GRAL stock between May 13, 2024, and February 19, 2026, and suffered losses are encouraged to contact the firm.

    Eagle-Tribune•8/4/26•
    Bearish

    Portnoy Law Firm Announces Class Action on Behalf of Grail, Inc. Investors

    The Portnoy Law Firm has announced a class action lawsuit on behalf of investors in Grail, Inc. (NASDAQ: GRAL) who purchased securities between May 13, 2025, and February 19, 2026. The lawsuit alleges that Grail made misleading statements and concealed material adverse facts regarding the true state of its NHS-Galleri trial, specifically concerning the sufficiency of the trial period to demonstrate a reduction in Stage III-IV cancers. Investors are encouraged to contact the firm to discuss their legal rights.

    GlobeNewswire•8/4/26•
    Bearish

    GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    Hagens Berman Sobol Shapiro LLP has filed a securities fraud class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL), urging investors with substantial losses to join before the August 4, 2026, lead plaintiff deadline. The lawsuit alleges that GRAIL and its executives misled investors about the NHS-Galleri cancer screening trial's design and efficacy, particularly concerning the sufficiency of its three-year follow-up period. GRAIL's stock plummeted by 50.55% on February 19, 2026, after the company disclosed that the trial failed to meet its primary endpoint and admitted to a flawed timeline, leading to over $2.2 billion in market cap loss.

    PR Newswire•8/4/26•
    Neutral

    GRAL IMPORTANT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important August 4 Deadline in Securities Class Action - GRAL

    GRAL IMPORTANT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important August 4 Deadline in Securities Class Action ...

    Business Insider•8/2/26•
    Somewhat-Bullish

    Frequently Asked Questions About GRAL

    Does GRAL pay dividends?
    GRAIL, LLC (GRAL) does not currently pay a regular dividend.
    What is GRAL's market cap?
    GRAIL, LLC (GRAL) has a market capitalization of $3.57B with a current stock price of $79.37.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In